Red X iconGreen tick iconYellow tick icon

Brain Health Research Centre

BHR’s mission is to undertake internationally excellent research aimed at understanding the mechanisms of brain health, disease and repair, to develop new treatments for neurological disorders, to provide international quality training for early-career neuroscientists, and to develop active educational links with the lay community.

Donate


CTCR Te Aho Matatū | Centre for Translational Cancer

Cancer research bridges the gap between laboratory-based science and treatment in the clinic. We now have sufficient knowledge in the fields of cancer biology, molecular biology, and immunology to make a significant impact on the treatment and management of cancer.

Visit the CTCR Te Aho Matatū | Centre for Translational Cancer website

Donate


COVID-19 Research

Donate


Edgar Diabetes and Obesity Research

We aim to reduce the prevalence, and to improve the management, of diabetes and obesity by finding new ways to prevent and treat these conditions. By striving for research excellence and encouraging international collaboration we can bring the greatest benefit to New Zealanders and the wider world.

Visit the Edgar Diabetes and Obesity Research website

Donate


Hereditary Diffuse Gastric Cancer (HDGC)

HDGC is an inherited cancer syndrome that was first identified in Aotearoa New Zealand but is now known to affect hundreds of families worldwide. HDGC family members have a very high risk of developing stomach cancer and breast cancer from a young age. Otago's research into HDGC aims to improve the treatment and care of these high-risk families.

Visit the Hereditary Diffuse Gastric Cancer research website

Donate


Lecturer in Chaplaincy Studies

Our goal is to raise an endowment fund of NZ$2 million to support a unique lecturer position in Chaplaincy Studies; the first in a New Zealand university dedicated to training Chaplains and enhancing their professional practice.

Donate


Vitamin C for Cancer

Ground-breaking research at Otago University, led by Prof Margreet Vissers and Assoc Prof Gabi Dachs, has identified new functions for vitamin C that suggest the vitamin may be a useful tool in cancer treatment. The research team is seeking funding for human trials to test this possibility.

We are currently working on the following projects:

  • Carrying out the first human clinical studies to measure how vitamin C accumulates in human cancers following high-dose therapy.
  • Measuring the effects of vitamin C on slowing cancer growth and working on understanding mechanisms of action.
  • Applying these studies to projects investigating vitamin C in: Breast cancer, Bowel cancer, Brain cancer, Leukaemia, Endometrial cancer, Kidney cancer.

Donate


Back to top